GPR55: metabolic help or hindrance?

Christopher Henstridge, Andrew J. Brown, Maria Waldhoer

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Since the discovery of the lysophospholipid-sensitive receptor GPR55, hopes have been raised that targeting this G protein-coupled receptor (GPCR) may represent a novel approach for the treatment of metabolic disorders. We discuss conflicting evidence surrounding GPR55 physiology and highlight its potential as a novel target for the treatment of obesity and diabetes.
Original languageEnglish
Pages (from-to)606-608
Number of pages3
JournalTrends in Endocrinology and Metabolism
Issue number9
Publication statusPublished - 21 May 2016


Dive into the research topics of 'GPR55: metabolic help or hindrance?'. Together they form a unique fingerprint.

Cite this